Grünewald, Julian
Zhou, Ronghao
Garcia, Sara P.
Iyer, Sowmya
Lareau, Caleb A.
Aryee, Martin J.
Joung, J. Keith
Article History
Received: 28 November 2018
Accepted: 9 April 2019
First Online: 17 April 2019
Competing interests
: J.K.J. has financial interests in Beam Therapeutics, Editas Medicine, Endcadia, Pairwise Plants, Poseida Therapeutics and Transposagen Biopharmaceuticals. These interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. J.K.J. and M.J.A. also hold equity in Excelsior Genomics. J.K.J. is a member of the Board of Directors of the American Society of Gene and Cell Therapy. J.G., R.Z. and J.K.J. are co-inventors on patent applications that have been filed by Partners Healthcare/Massachusetts General Hospital on engineered base editor architectures that reduce RNA editing activities.